How many institutions held COCP - Cocrystal Pharma, Inc. - Common Stock, par value $0.001 per share in Q4 2022?

18 institutional investors reported COCP - Cocrystal Pharma, Inc. - Common Stock, par value $0.001 per share for Q4 2022. Use the holders table for investor-level position and value details.

Cocrystal Pharma, Inc. - Common Stock, par value $0.001 per share (COCP)

Q: What does CUSIP 19188J409 represent in this 13F holders report?

CUSIP 19188J409 is the security identifier for COCP - Cocrystal Pharma, Inc. - Common Stock, par value $0.001 per share used to aggregate holder disclosures.

CUSIP: 19188J409

Q4 2022 13F Holders as of 31 Dec 2022

Type / Class: Equity / Common Stock, par value $0.001 per share
Shares outstanding: 13,831,528
Total 13F shares: 1,065,912
Share change: +1,065,894
Total reported value: $2,076,645
Price per share: $1.95
Number of holders: 18
Value change: +$2,076,610
Number of buys: 17

Quarterly Holders Quick Answers

What is CUSIP 19188J409?
CUSIP 19188J409 identifies COCP - Cocrystal Pharma, Inc. - Common Stock, par value $0.001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q1 2023

Recent filing periods for CUSIP 19188J409:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of COCP - Cocrystal Pharma, Inc. - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
SABBY MANAGEMENT, LLC	13F	Company	— class O/S missing	5,284,256	$1,538,000	—	30 Sep 2022	13F
VANGUARD GROUP INC	13F	Company	— class O/S missing	3,255,081	$948,000	—	30 Sep 2022	13F
RENAISSANCE TECHNOLOGIES LLC	13F	Company	— class O/S missing	1,604,425	$467,000	—	30 Sep 2022	13F
BlackRock Finance, Inc.	13F	Company	— class O/S missing	888,742	$259,000	—	30 Sep 2022	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	— class O/S missing	809,403	$235,000	—	30 Sep 2022	13F
MORGAN STANLEY	13F	Company	— class O/S missing	536,296	$156,000	—	30 Sep 2022	13F
STATE STREET CORP	13F	Company	— class O/S missing	293,290	$85,000	—	30 Sep 2022	13F
Parallel Advisors, LLC	13F	Company	— class O/S missing	182,708	$53,000	—	30 Sep 2022	13F
Verition Fund Management LLC	13F	Company	— class O/S missing	160,000	$47,000	—	30 Sep 2022	13F
NORTHERN TRUST CORP	13F	Company	— class O/S missing	143,474	$42,000	—	30 Sep 2022	13F
BANK OF AMERICA CORP /DE/	13F	Company	— class O/S missing	107,529	$31,000	—	30 Sep 2022	13F
CITADEL ADVISORS LLC	13F	Company	— class O/S missing	79,918	$23,000	—	30 Sep 2022	13F
Virtu Financial LLC	13F	Company	— class O/S missing	48,017	$14,000	—	30 Sep 2022	13F
Bank of New York Mellon Corp	13F	Company	— class O/S missing	44,522	$13,000	—	30 Sep 2022	13F
Tower Research Capital LLC (TRC)	13F	Company	— class O/S missing	32,675	$10,000	—	30 Sep 2022	13F
COMMONWEALTH EQUITY SERVICES, LLC	13F	Company	— class O/S missing	25,000	$7,000	—	30 Sep 2022	13F
TWO SIGMA SECURITIES, LLC	13F	Company	— class O/S missing	20,018	$6,000	—	30 Sep 2022	13F
B. Riley Wealth Advisors, Inc.	13F	Company	— class O/S missing	12,727	$4,000	—	30 Sep 2022	13F
MILLENNIUM MANAGEMENT LLC	13F	Company	— class O/S missing	10,555	$3,000	—	30 Sep 2022	13F
UBS Group AG	13F	Company	— class O/S missing	5,584	$2,000	—	30 Sep 2022	13F
Clean Yield Group	13F	Company	— class O/S missing	5,000	$1,000	—	30 Sep 2022	13F
JPMORGAN CHASE & CO	13F	Company	— class O/S missing	3,995	$1,000	—	30 Sep 2022	13F
Archer Investment Corp	13F	Company	— class O/S missing	1,000	$291	—	30 Sep 2022	13F

Institutional Holders of Cocrystal Pharma, Inc. - Common Stock, par value $0.001 per share (COCP) as of Q4 2022

As of 31 Dec 2022, Cocrystal Pharma, Inc. - Common Stock, par value $0.001 per share (COCP) was held by 18 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 1,065,912 shares. The largest 10 holders included SABBY MANAGEMENT, LLC, VANGUARD GROUP INC, RENAISSANCE TECHNOLOGIES LLC, BlackRock Inc., GEODE CAPITAL MANAGEMENT, LLC, MORGAN STANLEY, STATE STREET CORP, Parallel Advisors, LLC, NORTHERN TRUST CORP, and BANK OF AMERICA CORP /DE/. This page lists 18 institutional shareholders reporting positions in this security for the Q4 2022 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q4 2022 vs Q4 2025 Across Filers

Q4 2025 holders

Q4 2022 holders

Holder diff

-8

Investor	Q4 2025 Shares	Q4 2022 Shares	Share Diff	Share Chg %	Q4 2025 Value $	Q4 2022 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.